Immunexx

Bos Taurus Adrenal Gland, Sus Scrofa Adrenal Gland, Ascorbic Acid, Bos Taurus Bone Marrow, Sus Scrofa Bone Marrow, Bos Taurus Red Blood Cell, Sus Scrofa Red Blood Cell, Filgrastim, Aldesleukin, Interferon Gamma-1a, Bos Taurus Lymph, Sus Scrofa Lymph, Bos Taurus Peyers Patches, Sus Scrofa Small Intestine Mucosa Lymph Follicle, Bos Taurus Thymus, Sus Scrofa Thymus


Viatrexx Bio Incorporated
Human Otc Drug
NDC 63776-244
Immunexx also known as Bos Taurus Adrenal Gland, Sus Scrofa Adrenal Gland, Ascorbic Acid, Bos Taurus Bone Marrow, Sus Scrofa Bone Marrow, Bos Taurus Red Blood Cell, Sus Scrofa Red Blood Cell, Filgrastim, Aldesleukin, Interferon Gamma-1a, Bos Taurus Lymph, Sus Scrofa Lymph, Bos Taurus Peyers Patches, Sus Scrofa Small Intestine Mucosa Lymph Follicle, Bos Taurus Thymus, Sus Scrofa Thymus is a human otc drug labeled by 'Viatrexx Bio Incorporated'. National Drug Code (NDC) number for Immunexx is 63776-244. This drug is available in dosage form of Spray. The names of the active, medicinal ingredients in Immunexx drug includes Aldesleukin - 200 [kp_C]/mL Ascorbic Acid - 30 [kp_C]/mL Bos Taurus Adrenal Gland - 200 [kp_C]/mL Bos Taurus Bone Marrow - 30 [kp_C]/mL Bos Taurus Lymph - 200 [kp_C]/mL Bos Taurus Peyer's Patch - 200 [kp_C]/mL Bos Taurus Red Blood Cell - 200 [kp_C]/mL Bos Taurus Thymus - 200 [kp_C]/mL Filgrastim - 200 [kp_C]/mL Interferon Gamma-1a - 200 [kp_C]/mL and more. The currest status of Immunexx drug is Active.

Drug Information:

Drug NDC: 63776-244
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Immunexx
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Bos Taurus Adrenal Gland, Sus Scrofa Adrenal Gland, Ascorbic Acid, Bos Taurus Bone Marrow, Sus Scrofa Bone Marrow, Bos Taurus Red Blood Cell, Sus Scrofa Red Blood Cell, Filgrastim, Aldesleukin, Interferon Gamma-1a, Bos Taurus Lymph, Sus Scrofa Lymph, Bos Taurus Peyers Patches, Sus Scrofa Small Intestine Mucosa Lymph Follicle, Bos Taurus Thymus, Sus Scrofa Thymus
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Viatrexx Bio Incorporated
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Spray
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:ALDESLEUKIN - 200 [kp_C]/mL
ASCORBIC ACID - 30 [kp_C]/mL
BOS TAURUS ADRENAL GLAND - 200 [kp_C]/mL
BOS TAURUS BONE MARROW - 30 [kp_C]/mL
BOS TAURUS LYMPH - 200 [kp_C]/mL
BOS TAURUS PEYER'S PATCH - 200 [kp_C]/mL
BOS TAURUS RED BLOOD CELL - 200 [kp_C]/mL
BOS TAURUS THYMUS - 200 [kp_C]/mL
FILGRASTIM - 200 [kp_C]/mL
INTERFERON GAMMA-1A - 200 [kp_C]/mL
SUS SCROFA ADRENAL GLAND - 200 [kp_C]/mL
SUS SCROFA BONE MARROW - 30 [kp_C]/mL
SUS SCROFA LYMPH - 200 [kp_C]/mL
SUS SCROFA PEYER'S PATCH - 200 [kp_C]/mL
SUS SCROFA RED BLOOD CELL - 200 [kp_C]/mL
SUS SCROFA THYMUS - 200 [kp_C]/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 24 Jul, 2012
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 15 Jan, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:VIATREXX BIO INCORPORATED
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
NUI:N0000178328
N0000009391
M0011506
N0000175667
N0000193618
M0001797
M0024696
M0024695
N0000009451
N0000175666
Unique identifier applied to a drug concept within the National Drug File Reference Terminology (NDF-RT).
UNII:M89N0Q7EQR
PQ6CK8PD0R
M2776SWB29
08X0K2M57P
UGE0WQC19W
XB9AHC8DW1
5W4FLB0U2C
8XEJ88V2T8
PVI5M0M1GW
VC9M78242P
398IYQ16YV
VP2CN2G7Y8
33A7VYU29L
308LM01C72
5X23IGF970
7B69B0BD62
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.
Pharmacologic Class EPC:Lymphocyte Growth Factor [EPC]
Vitamin C [EPC]
Leukocyte Growth Factor [EPC]
Established pharmacologic class associated with an approved indication of an active moiety (generic drug) that the FDA has determined to be scientifically valid and clinically meaningful. Takes the form of the pharmacologic class, followed by `[EPC]` (such as `Thiazide Diuretic [EPC]` or `Tumor Necrosis Factor Blocker [EPC]`.
Pharmacologic Class PE:Increased Lymphocyte Activation [PE]
Increased Lymphocyte Cell Production [PE]
Increased Myeloid Cell Production [PE]
Physiologic effect or pharmacodynamic effect—tissue, organ, or organ system level functional activity—of the drug’s established pharmacologic class. Takes the form of the effect, followed by `[PE]` (such as `Increased Diuresis [PE]` or `Decreased Cytokine Activity [PE]`.
Pharmacologic Class CS:Interleukin-2 [CS]
Ascorbic Acid [CS]
Granulocyte Colony-Stimulating Factor [CS]
Granulocyte-Macrophage Colony-Stimulating Factor [CS]
Chemical structure classification of the drug product’s pharmacologic class. Takes the form of the classification, followed by `[Chemical/Ingredient]` (such as `Thiazides [Chemical/Ingredient]` or `Antibodies, Monoclonal [Chemical/Ingredient].
Pharmacologic Class:Ascorbic Acid [CS]
Granulocyte Colony-Stimulating Factor [CS]
Granulocyte-Macrophage Colony-Stimulating Factor [CS]
Increased Lymphocyte Activation [PE]
Increased Lymphocyte Cell Production [PE]
Increased Myeloid Cell Production [PE]
Interleukin-2 [CS]
Leukocyte Growth Factor [EPC]
Lymphocyte Growth Factor [EPC]
Vitamin C [EPC]
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
63776-244-141 BOTTLE, SPRAY in 1 BOX (63776-244-14) / 30 mL in 1 BOTTLE, SPRAY24 Jul, 2012N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose: adrenal gland adrenal support ascorbic acid anti-oxidant bone marrow immune support erythrocytes immune support granulocyte colony-stimulating factor immune support interleukin 2 immune support interferon gamma immune support lymph node immune support peyer's patches regeneration thymus regeneration

Product Elements:

Immunexx bos taurus adrenal gland, sus scrofa adrenal gland, ascorbic acid, bos taurus bone marrow, sus scrofa bone marrow, bos taurus red blood cell, sus scrofa red blood cell, filgrastim, aldesleukin, interferon gamma-1a, bos taurus lymph, sus scrofa lymph, bos taurus peyers patches, sus scrofa small intestine mucosa lymph follicle, bos taurus thymus, sus scrofa thymus alcohol water bos taurus adrenal gland bos taurus adrenal gland sus scrofa adrenal gland sus scrofa adrenal gland ascorbic acid ascorbic acid bos taurus bone marrow bos taurus bone marrow sus scrofa bone marrow sus scrofa bone marrow bos taurus red blood cell bos taurus red blood cell sus scrofa red blood cell sus scrofa red blood cell filgrastim filgrastim aldesleukin aldesleukin interferon gamma-1a interferon gamma-1a bos taurus lymph bos taurus lymph sus scrofa lymph sus scrofa lymph bos taurus peyer's patch bos taurus peyer's patch sus scrofa peyer's patch sus scrofa peyer's patch bos taurus thymus bos taurus thymus sus scrofa thymus sus scrofa thymus

Indications and Usage:

Uses to help support a healthy immune function

Warnings:

Warnings stop use and ask a health care practitioner if symptoms persist for more than five days or worsen. if pregnant or breastfeeding, ask a health care practitioner before use.

Dosage and Administration:

Dosage 1-3 spray(s); 1-3 time(s) per day or as recommended by your health care practitioner.

Package Label Principal Display Panel:

Principal display panel item: vpc0270 ndc 63776-244-14 homeopathic remedy immunexx • to help support a healthy immune function oral spray 30ml 1 oz viatrexx ™ bio incorporated manufactured by viatrexx www.viatrexx.com newark, de 19713 immunexx 30 ml 1 oz viatrexx ™ bio incorporated item: vpc0270 ndc: 63776-244-14 indications: to help support a healthy immune function directions: 1-3 spray(s); 1-3 time(s) per day or as recommended by your health care practitioner. mfg. for viatrexx bio incorporated. www.viatrexx.com newark, de 19713 immunexx box ingredients

Further Questions:

Questions info@viatrexx.com


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.